Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNBELIEVABLE: Dynavax technologies - The Untold Story

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022

Upgrades

Benzinga · Sep 27, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Benzinga · May 12, 2022

Dynavax Technologies Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q4, Dynavax Technologies (NASDAQ:DVAX) earned $99.78 million, a 450.96% increase from the preceding quarter. Dynavax Technologies also posted a total of $195.07 million in sales, a 80.17% increase since Q3.

Benzinga · Mar 2, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: Dynavax Technologies Q4 Earnings

Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 28, 2022

A Preview Of Dynavax Technologies's Earnings

Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Dynavax Technologies will report an earnings per share (EPS) of $0.69.

Benzinga · Feb 25, 2022

Coverage From

Benzinga

Organisations

Arcos Dorados Holdings

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.